Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer.
PLOS ONE Editors
PLoS ONE · 2018
doi:10.1371/journal.pone.0205300 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
After publication of this article [1], similarities were noted between the following pairs of images in Fig 5C:• Second AsPC-1 panel (GEM 20 nmol/L) and first CDF-pre-treated AsPC-1 panel (GEM 0 nmol/L)• Fourth and sixth AsPC-1 panels (GEM 40 nmol/L and CDF 6 μmol/L) Reference
Abstract licence: CC BY
References1
- 1.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.